East Bay Getting to Zero
Categories:
COVID, Epidemiology, Prevention, Youth

updated September 15, 2021

Fall 2021 marks the third academic year that schools have been impacted by the COVID-19 pandemic and is happening as the highly infectious delta variant spreads across the world. Nationwide in September 2021 case rates were highest among 5- to 17-year-olds, who also had the highest infection rates in the East Bay in August. While nationwide pediatric hospitalizations are still at record levels, driven by high hospitalization rates in southern states, the East Bay has had low pediatric hospitalization rates, thanks to high vaccination rates. Vax + masks remain our most effective tools for a safer school year and winter.

How do we reduce COVID transmissions in schools?

A delta variant outbreak at a Marin County elementary school in May-June 2021 demonstrates the importance of vaccinations for everyone eligible and strict universal masking, in addition to ventilation, routine testing and staying home when sick. The outbreak involved an unvaccinated teacher who took off their mask to read and subsequently spread COVID to at least half their students, despite the students remaining masked and 6 feet apart, the windows and doors being open, and having an air purifier in the classroom.

Using multiple prevention strategies together is crucial for reducing COVID-19 spread in the delta era. No single strategy is enough on its own, so we aim to do as many as possible with what we have. Here are the top evidence-based COVID risk reduction strategies:

  1. Vaccinations for everyone who is eligible.
  2. Universal mask wearing with multi-layered masks that stay over noses and mouths and fit tight against the face (top, sides, bottom). Surgical-type masks modified to fit well, double masking and fitted KF94s, KN95s and N95s are more effective than cloth masks alone.
  3. Maximizing ventilation by:
    • Having as many activities outdoors as possible, especially while eating/drinking, singing, shouting and exercising.
    • In classrooms and other indoor spaces by:
      • keeping windows and doors open for indoor/outdoor air exchange,
      • running fans to increase air flow at windows and doors,
      • running HVAC systems with MERV 13+ filters to clean the air, and
      • running HEPA air purifiers at the maximum rate tolerable starting at least an hour before class, during class and at least an hour after class to clean the air.
      • If the air quality is poor due to wildfires and you can’t keep windows and doors open, run the HVAC system and air purifiers at the highest settings tolerable.
  4. Maximizing distance by removing non-essential furniture, placing seats 3+ feet apart, facing desks the same direction, marking “safety zones” with colorful tape to remind students to distance, and keeping classroom cohorts apart. 
  5. Eye protection with enclosed goggles in the highest-risk settings, adding face shields to masks and/or by wearing glasses instead of contacts.
  6. Testing, symptom screening, staying home when sick, isolation and quarantine with routine testing at least 1-2 times per week, symptom screening and staying home when sick or with symptoms, contact tracing for COVID-19 cases, and quarantining when exposed to COVID-19. 
  7. Hand hygiene with frequent use of hand sanitizer and hand washing, especially before and after eating/drinking, touching faces and other people, using high-touch knobs, switches, the bathroom, playground and sports equipment.


The video
below is of a Q&A session on COVID school safety with Lincoln Elementary teachers in Oakland on August 25, 2021. You can also download a PDF of the slides.


Detailed tools, references and key studies


Key studies on COVID-19 risk reduction in schools

A nationwide study of in-person schooling, mitigation measures and COVID cases and symptoms found that while there were 30% more COVID cases in household when a child was in-person at school, when a school implemented 7 or more mitigation measures, case rates matched or fell below community case rates. The most common mitigation measures used in these schools included universal mask requirements, extra space between desks, restricted entry, no supply sharing, classroom cohorts, reduced class sized and symptom screening.



The following table summarizes a more nuanced approach to assessing risk and need to distance in different settings from BMJ, Jones et al.: “Two metres or one: what is the evidence for physical distancing in covid-19?” This article reviews the scientific evidence on physical distancing, argues that rigid distance rules are an oversimplification and offers a more nuanced model based on risk.


The largest randomized trial on the effectiveness of face masks in real-world settings, including 340,000 adults living in 600 communities in Bangladesh, showed that wearing masks, particularly surgical masks, is effective in reducing the spread of COVID-19 in community settings. The researchers’ 4-part “NORM” intervention (including no-cost/free masks, info about masks, role modeling and mask reminders) increased community mask-wearing by 3x and prevented 1 in 3 infections among people ages 60+ who are at highest risk for severe disease. Villages that used surgical-type masks had a greater reduction in symptomatic infection.

“These results suggest that we could prevent unnecessary death and disease if we get people to wear high-performance masks, such as surgical masks, in schools, workplaces, shopping centers, places of worship and other indoor spaces,” said study co-author Laura Kwong, an assistant professor of environmental health sciences at Berkeley’s School of Public Health. “I would strongly recommend that people who spend time in indoor public spaces, including students, wear surgical masks or other high-performance masks such as N95s, KN95s or KF94s. Fit and comfort are especially important for children, so child-sized KF94s may be most appropriate for them.”

More studies on safer school reopenings

California is requiring “All adults and students in K-12 school settings must wear masks indoors.”  The American Academy of Pediatrics released updated guidance for schools on July 17 also recommending masks for all people ages 2 and over in school and childcare settings.    

Multiple studies from 2020 have shown that schools can safely reopen with fewer transmissions than in the surrounding community when mitigation strategies with masking, distancing, cohorts, capacity limits and ventilation in place. However, current school guidance is based on studies done before the delta variant was prominent. Stricter implementation of these strategies is even more crucial during times of high community case rates and a surge in more infectious variants, like now. In a study from 2020 before Delta was widespread, British researchers found that for every five additional cases per 100,000 people in a community at large, the risk of a school outbreak increased 72%.

A study of a million students in North Carolina March-June 2021 (pre-delta) showed that proper universal masking is the most effective mitigation strategy for prevention COVID transmissions in schools when COVID-19 is circulating and students are ineligible for vaccination or uptake is inadequate. Fewer than 1% of the 40,000 in-school contacts of over 7,000 students and staff with diagnosed COVID-19 became infected while universal mask mandates were in place during a time when statewide case rates were around 15 cases/100k (5-23/100k range).

Other studies of schools in Utah, Missouri and Wisconsin showed that mask mandates were associated with lower transmissions in schools, and a study of a high school in Israel that didn’t use masks led to a large outbreak. Overall, these studies suggest a pre-delta 13% secondary attack rate in schools without masking and <1% secondary attack rate in schools with universal mask mandates. 

More studies on COVID and Youth

A CDC study shows that pediatric cases, ED visits and hospitalizations increased from June to August 2021 increased for people ages 0-17. The pediatric hospitalization rates were nearly 4 times higher in states in the lowest quartile of vaccination rates compared to the states in the highest quartile vaccination rates.

Evidence from the CDC demonstrates that compared to previous strains, the delta variant infects kids and unvaccinated people at higher rates in recreational settings, especially indoors, such as in this gymnastics facility where 20% at the gym were infected and 53% of household contacts became infected.

While most new infections are mild cases among young, unvaccinated people, there is still a risk of long-term health impacts that we don’t understand yet. A new study from Norway shows that more than half (52%) of young people ages 16-30 had long COVID symptoms.

 A large-scale Canadian public health study of 6,280 pediatric cases found that children ages 0 to 3 years had about 40% greater odds of transmitting COVID-19 to household contacts compared with children aged 14 to 17 years, based on pre-delta data collected between June 1 to Dec. 31, 2020.

Studies on vaccines for youth

Moderna and  Pfizer have reported data showing that their COVID-19 vaccine shows 100% efficacy in adolescents ages 12-15. With 2,260 adolescents participating in their trial, 18 people in the placebo group developed COVID-19 while none in the vaccinated group did. Blood antibody test data also show high titers of antibody responses in those who were vaccinated. On May 10th the FDA authorized use of the Pfizer vaccine for 12-15 year olds and on May 12th, the US Advisory Committee on Immunization Practices (ACIP) voted to recommend the Pfizer vaccine for 12-15 year olds.

Moderna announced on May 25 that their vaccine is 100% effective for 12-17 year olds in a clinical trial that enrolled 3,732 people ages 12 to 17, two-thirds of whom received two vaccine doses. There were no cases of symptomatic Covid-19 in fully vaccinated adolescents, the company reported. Moderna plans to submit data to the FDA for authorization in early June.  

The CDC has posted a statement on rare cases of myocarditis and pericarditis following mRNA vaccines, mostly mild cases among young cismen ages 30 and younger that occur a few days after the 2nd dose. Myocarditis and pericarditis can also be clinical features of COVID-19 infection, and the risk remains higher for COVID-19 infection cardiac complications among unvaccinated people.

Trials for children ages 6 months to 11 years old have also begun for both Pfizer and Moderna vaccines. Based on data from an earlier study that assessed safety, Pfizer will give two doses of 10 micrograms each (a third of the dose given to adolescents and adults) to children ages 5-11 years, and two doses of 3 micrograms each to children ages 6 months to 5 years.

A study suggests that MIS-C was a rare complication of SARS-CoV-2 infection but disproportionately impacts young people of color. “In this cohort study of 248 persons with MIS-C, MIS-C incidence was 5.1 persons per 1 000 000 person-months and 316 persons per 1 000 000 SARS-CoV-2 infections in persons younger than 21 years. Incidence was higher among Black, Hispanic or Latino, and Asian or Pacific Islander persons compared with White persons and in younger persons compared with older persons.”

A new article shares data from Brazil and Israel suggesting that mass adult vaccination protects children. Outbreaks in a small proportion of UK’s schools still show that children are still a reservoir of circulating virus.